Prime Medicine to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that company management will participate in the following upcoming conferences:
Read more at globenewswire.com
